Nilsson M, Fagman H, Ericson L E
Institute of Anatomy and Cell Biology, Göteborg University, Sweden.
Exp Cell Res. 1996 May 25;225(1):1-11. doi: 10.1006/excr.1996.0151.
The integrity of epithelial cell junctions is controlled by E-cadherin-mediated (Ca2+-dependent) cell-cell adhesion. In thyroid follicular cells the dissociation of junctions induced by transfer to low Ca2+ medium (Ca2+ switch) is prevented by thyrotropin acting via cyclic AMP/protein kinase A (cAMP/PKA) (Nilsson et al., Eur. J. Cell Biol. 56, 308-318, 1991). In MDCK kidney epithelial cells protein kinase inhibitors elicit a similar response which, however, is cadherin-independent (Citi, J. Cell Biol. 117,169-178,1992; Citi et al., J. Cell Sci. 107, 683-692, 1994). As such inhibitors also may interfere with PKA, we examined in a single cell type, filter-cultured pig thyrocytes, the effects and possible interactions of the cAMP/PKA agonist forskolin (or thyrotropin) and the kinase inhibitor H-7 in Ca2+ switch experiments. We found that the epithelial barrier dysfunction, comprising loss of transepithelial resistance, increased transepithelial flux of [3H]inulin and redistribution of junction proteins (cadherin and ZO-1), which follows Ca2+ removal were inhibited by TSH, forskolin, and H-7. All agents were also able to induce recovery of resistance in low Ca2+. The maximal recovery effects of forskolin and H-7 were additive when given simultaneous with Ca2+ chelator. In contrast, forskolin-induced recovery initiated 10 min after Ca2+ removal was antagonized by H-7. The protection of junctions by forskolin in low Ca2+ was rapidly abolished by light trypsinization (0.001%), whereas the same concentration of trypsin had little or no effect on the corresponding action of H-7 or staurosporine, another potent kinase inhibitor. In H-7-treated cells kept in low Ca2+, trypsin caused redistribution of ZO-1 from the plasma membrane to the cytoplasm while the transepithelial resistance remained high. Taken together, the data indicate that TSH via cAMP/PKA and the protein kinase inhibitor H-7 reinforce the thyroid epithelial barrier under low Ca2+ conditions by distinct although interacting mechanisms. The high sensitivity to proteolysis in the absence of Ca2+ suggests that the cAMP-regulated mechanism is cadherin-dependent. H-7 promotes or inhibits the cAMP/PKA-mediated recovery of transepithelial resistance depending on the duration of the preceding low Ca2+ period. The trypsin-induced displacement of ZO-1 in H-7-treated cells in low Ca2+ suggests that the localization of ZO-1 to the tight junction is not necessary for the maintenance of junctional tightness.
上皮细胞连接的完整性由E-钙黏蛋白介导的(钙离子依赖性)细胞间黏附控制。在甲状腺滤泡细胞中,促甲状腺激素通过环磷酸腺苷/蛋白激酶A(cAMP/PKA)起作用,可防止转移至低钙培养基(钙离子转换)诱导的连接解离(尼尔森等人,《欧洲细胞生物学杂志》56卷,308 - 318页,1991年)。在MDCK肾上皮细胞中,蛋白激酶抑制剂引发类似反应,然而,这是不依赖钙黏蛋白的(西蒂,《细胞生物学杂志》117卷,169 - 178页,1992年;西蒂等人,《细胞科学杂志》107卷,683 - 692页,1994年)。由于此类抑制剂也可能干扰PKA,我们在单一细胞类型即滤膜培养的猪甲状腺细胞中,研究了cAMP/PKA激动剂福斯可林(或促甲状腺激素)和激酶抑制剂H - 7在钙离子转换实验中的作用及可能的相互作用。我们发现,钙离子去除后出现的上皮屏障功能障碍,包括跨上皮电阻丧失、[3H]菊粉跨上皮通量增加以及连接蛋白(钙黏蛋白和ZO - 1)重新分布,均受到促甲状腺激素、福斯可林和H - 7的抑制。所有试剂还能够在低钙条件下诱导电阻恢复。当与钙离子螯合剂同时给予时,福斯可林和H - 7的最大恢复效果是相加的。相反,钙离子去除10分钟后开始的福斯可林诱导的恢复被H - 7拮抗。在低钙条件下,轻度胰蛋白酶消化(0.001%)可迅速消除福斯可林对连接的保护作用,而相同浓度的胰蛋白酶对H - 7或另一种强效激酶抑制剂星形孢菌素的相应作用几乎没有影响。在低钙条件下用H - 7处理的细胞中,胰蛋白酶导致ZO - 1从质膜重新分布到细胞质,而跨上皮电阻仍保持较高。综上所述,数据表明促甲状腺激素通过cAMP/PKA和蛋白激酶抑制剂H - 7在低钙条件下通过不同但相互作用的机制增强甲状腺上皮屏障。在缺乏钙离子时对蛋白水解的高敏感性表明cAMP调节机制是依赖钙黏蛋白的。H - 7促进或抑制cAMP/PKA介导的跨上皮电阻恢复,这取决于先前低钙期的持续时间。胰蛋白酶在低钙条件下诱导H - 7处理的细胞中ZO - 1移位,这表明ZO - 1定位于紧密连接对于维持连接紧密性并非必要。